Aggregation-induced emission nanoparticle and preparation method and application thereof
A technology of aggregation-induced luminescence and nano-particles, which is applied in the field of medical materials, can solve the problems of interfering with the normal physiological functions of cells, the toxicity of quantum dots with heavy metals, and the reduction of fluorescence intensity, so as to achieve cell survival and differentiation ability without interference and good tracer effect, the effect of high luminous efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0038] Example 1
[0039] A method for preparing aggregation-induced luminescent nanoparticles includes the following steps:
[0040] (1) Distearoylphosphatidylethanolamine-polyethylene glycol-2000 (1mg), distearoylphosphatidylethanolamine-polyethylene glycol-2000-maleic anhydride (1mg), compound shown in formula I (R 1 -R 9 All hydrogen) (1 mg) was dissolved in 1 mL of tetrahydrofuran, and 9 mL of distilled water was added under ultrasound (80% output, SCIENTZ-II D ultrasonic instrument), and the ultrasound was continued for 2 minutes to prepare AIE nanoparticles modified with maleic anhydride.
[0041] (2) The tetrahydrofuran is subsequently removed by volatilization, and further filtered through a 0.2 μm filter to remove precipitates and large particulate matter. The cell penetrating polypeptide Tat (RKKRRQRRRC) (SEQ ID No. 1) was added to the filtrate, and after reacting overnight at room temperature, the excess polypeptide was removed by dialysis to prepare AIE nanoparticles th...
Example Embodiment
[0043] Example 2
[0044] A method for preparing aggregation-induced luminescent nanoparticles includes the following steps:
[0045] (1) Distearoylphosphatidylethanolamine-polyethylene glycol-2000 (1mg), distearoylphosphatidylethanolamine-polyethylene glycol-2000-carboxyl (1mg), the compound shown in formula I (R 3 It is tert-butyl and other substituents are hydrogen) (1mg) dissolved in 1mL of tetrahydrofuran, added to 9mL of distilled water under ultrasound (80% output, SCIENTZ-II D sonicator), and directly prepared surface modified Arima by nanoprecipitation method AIE nanoparticles made of acid anhydride.
[0046] (2) The tetrahydrofuran is subsequently removed by volatilization, and further filtered through a 0.2 μm filter to remove precipitates and large particulate matter. Add cell penetrating polypeptide Tat (RKKRRQRRRC) (SEQ ID No.1), 69μg 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 78μg N-hydroxyl to the filtrate After reacting overnight at room temper...
Example Embodiment
[0047] Example 3
[0048] A method for preparing aggregation-induced luminescent nanoparticles includes the following steps:
[0049] (1) Distearoylphosphatidylethanolamine-polyethylene glycol-2000 (1mg), distearoylphosphatidylethanolamine-polyethylene glycol-2000-amino (1mg), the compound shown in formula I (R 3 It is a carboxyl group and other substituents are hydrogen) (1mg) dissolved in 1mL of tetrahydrofuran, added to 9mL of distilled water under ultrasound (80% output, SCIENTZ-II D sonicator), and directly prepared surface-modified maleic anhydride by nanoprecipitation AIE nanoparticles.
[0050] (2) The tetrahydrofuran is subsequently removed by volatilization, and further filtered through a 0.2 μm filter to remove precipitates and large particulate matter. Add cell penetrating polypeptide Tat (RKKRRQRRRC) (SEQ ID No.1), 69μg 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 78μg N-hydroxyl to the filtrate After reacting overnight at room temperature, sulfosucc...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap